Literature DB >> 22576970

Sclerotic osseous metastases from renal cell carcinoma.

Darryl B Sneag1, Katherine M Krajewski, Stephanie Howard, Jyothi P Jagannathan, Kremena V Star, Nikhil Ramaiya.   

Abstract

This case series describes and illustrates three cases of sclerotic osseous metastases from untreated renal cell carcinoma (RCC). RCC is commonly metastatic to the skeleton but almost always produces lytic metastases, with only three prior reports of sclerotic metastases identified in the literature. Sclerotic metastasis causing low back pain was the initial disease presentation in two of the three patients in this case series and the first manifestation of metastatic disease in one. The most common metastatic sites of RCC, i.e., retroperitoneal lymph nodes, lung, and liver, were not identified in any of the cases, and skeletal involvement with epidural extension was the only site of metastasis in two. Pathologic specimens from all three cases revealed RCC of high nuclear grade.

Entities:  

Mesh:

Year:  2012        PMID: 22576970     DOI: 10.1007/s00256-012-1424-3

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  19 in total

Review 1.  Mechanisms of bone metastasis.

Authors:  G David Roodman
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

2.  Osteoblastic metastases in renal cell carcinoma.

Authors:  A I Neugut; E S Casper; T A Godwin; J Smith
Journal:  Br J Radiol       Date:  1981-11       Impact factor: 3.039

Review 3.  Mechanisms of cancer metastasis to the bone.

Authors:  Juan Juan Yin; Claire B Pollock; Kathleen Kelly
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

4.  Unclassified renal cell carcinoma: impact on survival following nephrectomy.

Authors:  Paul L Crispen; Mitra R Tabidian; Cristine Allmer; Christine M Lohse; Rodney H Breau; Michael L Blute; John C Cheville; Bradley C Leibovich
Journal:  Urology       Date:  2010-03-12       Impact factor: 2.649

5.  Unclassified renal cell carcinoma: an analysis of 85 cases.

Authors:  Pierre I Karakiewicz; Georg C Hutterer; Quoc-Dien Trinh; Allan J Pantuck; Tobias Klatte; John S Lam; Francois Guille; Alexandre de La Taille; Giacomo Novara; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Luigi Schips; Richard Zigeuner; Peter F Mulders; Denis Chautard; Eric Lechevallier; Antoine Valeri; Jean-Luc Descotes; Herve Lang; Michel Soulie; Jean-Marie Ferriere; Christian Pfister; Arnaud Mejean; Arie S Belldegrun; Jean-Jacques Patard
Journal:  BJU Int       Date:  2007-10       Impact factor: 5.588

6.  Differences in organ system of distant metastasis by renal cell carcinoma subtype.

Authors:  Nathan E Hoffmann; Michael D Gillett; John C Cheville; Christine M Lohse; Bradley C Leibovich; Michael L Blute
Journal:  J Urol       Date:  2008-02       Impact factor: 7.450

7.  Radiographic manifestations of bone metastases from renal carcinoma.

Authors:  G S Forbes; R A McLeod; R R Hattery
Journal:  AJR Am J Roentgenol       Date:  1977-07       Impact factor: 3.959

8.  Solid renal tumors: an analysis of pathological features related to tumor size.

Authors:  Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

Review 9.  Role of endothelin-1 in osteoblastic bone metastases.

Authors:  Theresa A Guise; Juan Juan Yin; Khalid S Mohammad
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

10.  Skeletal metastases in 102 patients evaluated before surgery for renal cell carcinoma.

Authors:  C Henriksson; G Haraldsson; F Aldenborg; S Lindberg; S Pettersson
Journal:  Scand J Urol Nephrol       Date:  1992
View more
  2 in total

1.  Renal cell carcinoma: an unusual case of sclerotic metastasis.

Authors:  Kaouther Ben Abdelghani; Maroua Slouma; Leila Souabni; Leith Zakraoui
Journal:  BMJ Case Rep       Date:  2014-09-19

2.  Osteoblastic bone metastases from renal cell carcinoma.

Authors:  Vladka Salapura; Irena Zupan; Bostjan Seruga; Gorana Gasljevic; Pavel Kavcic
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.